RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 154 filers reported holding RA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 7.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $6,000 | -78.6% | 121 | -79.7% | 0.00% | -100.0% |
| Q4 2019 | $28,000 | +86.7% | 596 | -6.1% | 0.00% | +100.0% |
| Q3 2019 | $15,000 | -65.9% | 635 | -73.5% | 0.00% | -66.7% |
| Q4 2018 | $44,000 | +18.9% | 2,397 | -35.0% | 0.00% | +50.0% |
| Q2 2018 | $37,000 | +428.6% | 3,690 | +197.8% | 0.00% | +100.0% |
| Q1 2018 | $7,000 | -53.3% | 1,239 | -27.7% | 0.00% | -50.0% |
| Q4 2017 | $15,000 | -76.9% | 1,713 | -61.2% | 0.00% | -60.0% |
| Q3 2017 | $65,000 | +622.2% | 4,411 | +858.9% | 0.01% | +400.0% |
| Q2 2017 | $9,000 | +350.0% | 460 | +360.0% | 0.00% | – |
| Q1 2017 | $2,000 | +100.0% | 100 | +47.1% | 0.00% | – |
| Q4 2016 | $1,000 | – | 68 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,138,797 | $294,724,000 | 15.40% |
| RA Capital Management | 4,858,260 | $233,245,000 | 7.37% |
| HAVENS ADVISORS LLC | 143,266 | $6,878,000 | 6.70% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 609,614 | $29,267,000 | 6.40% |
| OMNI PARTNERS LLP | 1,052,744 | $50,542,000 | 4.45% |
| HBK INVESTMENTS L P | 2,004,042 | $96,214,000 | 4.03% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,005,600 | $96,289,000 | 3.83% |
| Versor Investments LP | 1,108,845 | $53,236,000 | 3.53% |
| OXFORD ASSET MANAGEMENT LLP | 461,016 | $22,133,000 | 3.12% |
| HighVista Strategies LLC | 63,222 | $3,035,000 | 2.81% |